News & Articles

The U.S. Food and Drug Administration has approved Tabrecta (capmatinib) to treat adult patients with non-small cell lung cancer

Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients

Innovosens building partnerships to accelerate development, testing and market launch

The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19

Automated workflow optimized to extract pure DNA/RNA from the novel coronavirus, SARS-CoV-2

The serology test promises 100% sensitivity and can help assess patients' immune response to the virus

The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment

Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.

Collaboration will enable global development, manufacturing and distribution of the vaccine

These models aim to accelerate treatment development prior to clinical trials

The test will be available for qualified laboratories across the European Union by the end of May

Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19

The German-based biotech company specializes in process development for recombinant vaccines

Comprehensive turnkey system based on LabVantage LIMS platform allows laboratories to implement COVID-19 Biobanking, testing and research

Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April

Pioneering new class of diagnostic product will transform fight against pandemic

Watch this on-demand webinar to understand how better research diagnostic methods can lead to improved treatment of congenital metabolopathies

This strategic partnership aims to expand access to the Tapestri Platform for single-cell multiomics

The combination of the unique technologies aims to bring a novel angle to combat the global pandemic

Catch up on this on-demand webinar to learn how researchers at LifeArc are investigating a novel approach to targeting ALK-expressing neuroblastoma cells

The device enables researchers to analyze their cell cultures remotely, hence minimizing time spent in high-containment labs

The AIHTA have published a comprehensive overview of current research and development activities for evidence-based policy advice